Stockscreener 앱 받기
7.435
72.66%
3.155
전일 마감가:
$4.28
열려 있는:
$8.8
하루 거래량:
60.38M
Relative Volume:
364.03
시가총액:
$6.15M
수익:
$275.60K
순이익/손실:
$-8.33M
주가수익비율:
-16.10
EPS:
-0.4619
순현금흐름:
$-5.40M
1주 성능:
+69.71%
1개월 성능:
+8.68%
6개월 성능:
+1,985%
1년 성능:
+739.96%
1일 변동 폭
$6.80
$10.98
1주일 범위
$4.10
$10.98
52주 변동 폭
$0.2201
$10.98
Nexalin Technology Inc Stock (NXL) Company Profile
명칭
Nexalin Technology Inc
전화
(832) 260-0222
주소
1776 YORKTOWN, HOUSTON
Compare NXL vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
7.415 | 3.64M | 275.60K | -8.33M | -5.40M | -0.4619 |
ABT
Abbott Laboratories
|
96.70 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.05 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
273.15 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.12 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nexalin Technology Inc 주식(NXL)의 최신 뉴스
NXL Should I Buy - Intellectia AI
Nexalin Technology Inc. (NASDAQ: NXL) Share Price, NXL Stock News, NXL Share Price & Updates - kalkine.com.au
Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - ACCESS Newswire
Nexalin Technology (NXL) Slips 3.94% to $4.85 as Shares Drift Toward Lower SupportGolden Cross - dars.gov.et
Nexalin Technology (NXL) Declines 5.34% to $4.79, Pressuring Key Support LevelSupply Zone - siam.in
Nexalin Technology Announces Key Executive Leadership Departure - TipRanks
Nexalin Technology registers to sell 5.75M shares of common stock for holders - TipRanks
Multi-million-share resale could boost Nexalin (NASDAQ: NXL) share count - Stock Titan
Greenlight Ventures Discloses Investment at Nexalin Technology with 5.6% Stake - TradingView
Stock-for-deal investor steps in at Nexalin (NASDAQ: NXL) - Stock Titan
Nexalin Technology (NASDAQ: NXL) Announces Carolyn Shelton's Exit with $20,000 Bonus and Accelerated Stock Option Vesting - kalkinemedia.com
Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to - Yahoo Finance
Nexalin Technology Announces New Secondary Analysis of - GlobeNewswire
Carolyn Shelton exits Nexalin as Senior VP; separation terms include bonus and option vesting - TradingView
Nexalin Technology, Inc. Announces Resignation of Carolyn Shelton from Senior Vice President of Quality, Regulatory, and Clinical Affairs, Effective August 28, 2026 - marketscreener.com
Alumni Capital LP Holds 9.99% Stake in Nexalin Technology (NASDAQ: NXL), Disclosing 2.49 Million Shares - Kalkine Media
Nexalin Announces 1-for-30 Reverse Stock Split Approval - The Globe and Mail
Nexalin Technology approves 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Nexalin Technology (NXL) draws new near-10% investor stake - Stock Titan
Nexalin (NXL) Levels: Ends Higher by 0.45% at $0.33 in the Latest Reading - careplusvn.com
Nexalin Technology Raises Liquidity via Short-Term Note - TipRanks
Nexalin Technology Issues $1.17 Million OID Note for $1.0 Million Proceeds - TradingView
Nexalin Announces Capital Raise and Flexible Equity Facility - TipRanks
Nexalin Technology Raises $750,000 in Registered Direct Offering - minichart.com.sg
Nexalin Technology Announces $0.75M Direct Offering and $15M Equity Purchase Facility With Alumni Capital - TradingView
Nexalin (NXL) EPS and Revenue: EPS Does Not Reach the Reported Estimate in the Available Record; The Share Price Sheds 2.06% in Latest TradingEPS Guidance Update - dars.gov.et
Nexalin Faces New Nasdaq Equity Deficiency, Delisting Risk - The Globe and Mail
Nexalin Technology Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nexalin Technology earnings missed, revenue fell short of estimates By Investing.com - Investing.com South Africa
Nexalin Technology Inc (NXL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nexalin Technology earnings missed, revenue fell short of estimates - Investing.com
Nexalin Technology (NXL) Edges Higher at $0.36 as Neurostimulation Stock Holds Key SupportIceberg Order - dars.gov.et
Nexalin Technology, Inc. 2Q 2026: Revenue $12.16K, EPS ($0.11) — 10-Q Summary - TradingView
Nexalin Technology (NXL) flags going concern risk as losses mount and Nasdaq warns - Stock Titan
Nexalin Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nexalin Technology | 8-K: Current report - Moomoo
Nexalin Technology Inc (NXL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nexalin Technology Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Nexalin Expands and Extends Houston Headquarters Lease Commitment - The Globe and Mail
Nexalin Appeals Nasdaq Delisting Following Compliance Shortfalls - The Globe and Mail
Nexalin Technology Inc (NXL) Institutional Confidence - TradingKey
Nexalin Technology Received Notice of Delisting - TradingView
Nexalin Technology Inc (NXL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NXL|Nexalin Technology Inc|Price:0.353|Chg%:+0.014 - TradingKey
Nexalin Technology Inc (NXL) Cash Flow - TradingKey
Nexalin Technology Inc (NXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NXL|Nexalin Technology Inc|Price:0.500|Chg%:+0.019 - TradingKey
Nexalin Technology Inc (NXL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nexalin Technology Inc (NXL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
NXL|Nexalin Technology Inc|Price:0.481|Chg%:+0.013 - TradingKey
NXL Q1 2026 Earnings: EPS Misses Estimates as Company Advances Non-Invasive Neuromodulation PipelineDividend Cut Risk - careplusvn.com
Nexalin Technology Inc (NXL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.18%
0.31%
자본화:
|
볼륨(24시간):